Encapsulating Rifampicin into SLNs: A Viable Option for Managing its Bioavailability Issues Upon Co-Delivery with Isoniazid.
Curr Drug Deliv
; 17(4): 343-347, 2020.
Article
in En
| MEDLINE
| ID: mdl-32077827
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Rifampin
/
Nanoparticles
/
Isoniazid
/
Lipids
Limits:
Animals
Language:
En
Journal:
Curr Drug Deliv
Journal subject:
FARMACIA
/
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2020
Document type:
Article
Affiliation country:
India
Country of publication:
Emiratos Árabes Unidos